Dr Jiageng Guo | Microstructure and Properties | Best Researcher Award

Dr Jiageng Guo, Guangxi university of Chinese Medicine, China

Dr. Jiageng Guo is a distinguished researcher at Guangxi University of Traditional Chinese Medicine, specializing in pharmacology and cancer research. He has made significant contributions to liver cancer therapy, focusing on natural compounds like cinnamaldehyde and cinnamic acid. His work spans cutting-edge areas, including network pharmacology, bioinformatics, and both in vitro and in vivo experimental techniques. With high-impact publications in journals like Frontiers in Pharmacology, Dr. Guo integrates Traditional Chinese Medicine with modern pharmacology. His interdisciplinary approach offers innovative solutions for cancer therapy and drug discovery.

Publication Profile

Scopus

Skills

Guo Jiageng is highly skilled in network pharmacology and bioinformatics analysis, essential for understanding complex biological systems and drug interactions. He is proficient in various in vitro cell experimental techniques, including flow cytometry, cell proliferation, apoptosis, migration, invasion, and cell cycle analysis . Additionally, he has hands-on experience with in vivo experimental models, such as constructing zebrafish PDX models, performing zebrafish seahorse detection , and establishing mouse tumor-bearing models . These techniques are critical for advancing research in pharmacology and cancer therapy.

Education

Dr. Guo is a distinguished academic at Guangxi University of Traditional Chinese Medicine, where he combines the rich heritage of traditional Chinese medicine with modern scientific research methodologies. His diverse academic background allows him to integrate a wide range of scientific knowledge, especially in the fields of pharmacology and holistic healing. With expertise in both traditional practices and contemporary research, Dr. Guo is well-positioned to explore and advance the understanding of Chinese medicine in the modern scientific landscape. His work bridges the gap between ancient wisdom and cutting-edge medical innovations.

Experience

From September 2022 to September 2024, Guo Jiageng dedicated his efforts to research on the therapeutic mechanisms of cinnamaldehyde and cinnamic acid in liver cancer treatment. His work explored crucial energy metabolism pathways and the EGFR pathway, aiming to uncover their potential in combating cancer cells . Through these studies, he contributed valuable insights into the molecular processes involved in liver cancer therapy, paving the way for novel treatments and therapeutic strategies .

Research Focus Area

Dr. Jiageng Guo’s research primarily focuses on Traditional Chinese Medicine (TCM), pharmacology, and its applications in health restoration. His work includes investigating natural compounds like cinnamaldehyde and Cinnamomi Cortex for therapeutic effects, particularly in skin barrier restoration and cancer treatment. Dr. Guo explores the molecular mechanisms underlying these herbal treatments, such as the role of GSK-3β in liver cancer through the PI3K/AKT pathway . His research bridges traditional herbal medicine with modern biomedical advancements , highlighting the potential of TCM in improving skin health and combating diseases.

Publication Top Notes

Insights from Traditional Chinese Medicine for Restoring Skin Barrier Functions

Visual analysis of knowledge graph for research progress on medicinal and edible traditional Chinese medicine Cinnamomi Cortex based on VOSviewer and CiteSpace

Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway

Advances in pharmacological effects and mechanism of action of cinnamaldehyde

Conclusion

Dr. Jiageng Guo is undoubtedly a suitable candidate for the Best Researcher Award, given his extensive research background, significant publications in top journals, mastery of diverse experimental techniques, and his impactful contributions to both modern cancer research and traditional medicine. His work is poised to make meaningful advancements in therapeutic development, particularly for liver cancer, and his multi-disciplinary approach offers considerable promise for future breakthroughs.